Patents by Inventor Claude Artois

Claude Artois has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition
    Patent number: 7144703
    Abstract: Novel vaccine compositions are provided comprising a hepatitis B antigen formulated with aluminium phosphate. The vaccine compositions may additionally contain an inactivated hepatitis A virus, aluminium hydroxide and formol. The combined hepatitis A and B vaccine formulations can, if desired, be administered to human subjects in a 2 dose regimen. Suitable formulations are illustrated.
    Type: Grant
    Filed: July 1, 2004
    Date of Patent: December 5, 2006
    Assignee: SmithKline Beecham Biologicals, s.a.
    Inventors: Claude Artois, Michael J Clark, Stefan Gabriel Jozef Thoelen, Clothilde Thiriart
  • Novel composition
    Publication number: 20040241193
    Abstract: Novel vaccine compositions are provided comprising a hepatitis B antigen formulated with aluminium phosphate. The vaccine compositions may additionally contain an inactivated hepatitis A virus, aluminium hydroxide and formol. The combined hepatitis A and B vaccine formulations can, if desired, be administered to human subjects in a 2 dose regimen. Suitable formulations are illustrated.
    Type: Application
    Filed: July 1, 2004
    Publication date: December 2, 2004
    Applicant: SmithKline Beecham Biologicals, s.a.
    Inventors: Claude Artois, Michael J. Clark, Stefan Gabriel Jozef Thoelen, Clothilde Thiriart
  • Novel composition
    Publication number: 20030049268
    Abstract: Novel vaccine compositions are provided comprising a hepatitis B antigen formulated with aluminium phosphate. The vaccine compositions may additionally contain an inactivated hepatitis A virus, aluminium hydroxide and formol. The combined hepatitis A and B vaccine formulations can, if desired, be administered to human subjects in a 2 dose regimen. Suitable formulations are illustrated.
    Type: Application
    Filed: August 20, 2002
    Publication date: March 13, 2003
    Applicant: SmithKline Beecham Biologicals s.a.
    Inventors: Claude Artois, Michael J. Clark, Stefan Gabriel Jozef Thoelen, Clothilde Thiriart
  • Vaccine composition
    Publication number: 20030022304
    Abstract: This invention relates to a general method by which either extemporaneously prepared or liquid Hib/DTPa combination vaccines can be made in order to avoid Hib interference while being able to maintain the maximum, stable adsorption of each antigen onto the aluminium-based adjuvant on which it is most immunogenic. In so doing, pertussis antigens in combination vaccines of the present invention are stably retained in their most potent form.
    Type: Application
    Filed: August 13, 2002
    Publication date: January 30, 2003
    Applicant: SmithKline Beecham Biologicals, s.a.
    Inventors: Claude Artois, Koen De Heyder, Pierre Desmons, Nathalie Garcon, Roland Mainil